8-K: Safeguard Scientifics to Voluntarily Delist from Nasdaq, Plans OTC Trading

Safeguard Scientifics has announced its intention to delist from Nasdaq and transition to over-the-counter trading, following a reverse and forward stock split.

Summary

• Safeguard Scientifics intends to voluntarily delist its common stock from the Nasdaq Stock Market.
• The company plans to file Form 25 with the SEC on February 2, 2024, with delisting expected ten days after.
• Following delisting, the company intends to deregister its common stock under the Securities Exchange Act of 1934 by filing a Form 15 with the SEC.
• The company expects to have less than 300 shareholders of record after the delisting.
• Trading of the company's common stock is expected to move to privately negotiated sales and potentially an over-the-counter market.
• The company anticipates its stock will be quoted on a market operated by OTC Markets Group Inc.
• A reverse stock split at a ratio of 1-for-100, followed immediately by a forward stock split at a ratio of 100-for-1, was completed on January 12, 2024.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the document outlines a planned strategic move to delist and move to the OTC market. While this may reduce costs, it also carries risks related to liquidity and visibility.

Positives

• The company is taking steps to reduce costs associated with being a publicly listed company.
• The company expects to have its common stock quoted on an OTC market, allowing for continued trading.

Negatives

• The delisting from Nasdaq may reduce the visibility and liquidity of the company's stock.
• There is no guarantee that a broker will continue to make a market in the common stock on the OTC market.
• The company will no longer be subject to the same level of regulatory scrutiny as a Nasdaq-listed company.

Risks

• There is no guarantee that a broker will continue to make a market in the common stock on the OTC market.
• Trading of the common stock may be less liquid and more volatile on the OTC market.
• The company's ability to raise capital in the future may be impacted by the delisting.
• The company's projected cost savings may not be fully realized.
• The company's forward-looking statements are subject to risks and uncertainties.

Future Outlook

The company expects to have its common stock quoted on an OTC market, but there is no guarantee that a broker will continue to make a market in the common stock. The company is pursuing a focused strategy to value-maximize and monetize its ownership interests over a multi-year time frame to drive shareholder value.

Management Comments

• The company is pursuing a focused strategy to value-maximize and monetize its ownership interests over a multi-year time frame to drive shareholder value.

Industry Context

Companies sometimes delist from major exchanges to reduce costs and regulatory burdens, especially if they have a small shareholder base or are undergoing significant strategic changes. Moving to the OTC market is a common alternative for companies that no longer meet the listing requirements of major exchanges.

Comparison to Industry Standards

• Delisting from major exchanges and moving to OTC markets is a strategy sometimes employed by smaller companies or those undergoing restructuring, such as companies like China Ceramics Co., Ltd. which delisted from Nasdaq in 2023.
• Reverse stock splits followed by forward stock splits are sometimes used to maintain listing compliance or to adjust share prices, similar to actions taken by companies like Cassava Sciences, Inc. in the past.
• The move to OTC markets is often seen as a way to reduce costs and regulatory burdens, which is a common motivation for companies like Sears Holdings Corp. after its delisting from Nasdaq.

Stakeholder Impact

• Shareholders will experience a change in trading venue from Nasdaq to the OTC market.
• Shareholders may experience reduced liquidity and potentially increased volatility in the stock price.
• Employees may be impacted by the company's strategic shift and cost-cutting measures.
• Customers and suppliers may not be directly impacted by the delisting.

Next Steps

• File Form 25 with the SEC on February 2, 2024.
• Delist from Nasdaq ten days after filing Form 25.
• File Form 15 with the SEC to deregister the common stock.
• Transition trading to privately negotiated sales and potentially an over-the-counter market.
• Have common stock quoted on a market operated by OTC Markets Group Inc.

Key Dates

Keywords

delisting, Nasdaq, OTC, reverse stock split, forward stock split, deregistration, Form 25, Form 15, shareholders